| Record ID | marc_loc_2016/BooksAll.2016.part29.utf8:180154429:1270 |
| Source | Library of Congress |
| Download Link | /show-records/marc_loc_2016/BooksAll.2016.part29.utf8:180154429:1270?format=raw |
LEADER: 01270cam a22003494a 4500
001 2002016154
003 DLC
005 20080311090131.0
008 020130s2002 nyua b 001 0 eng
010 $a 2002016154
020 $a0306467453
035 $a(DNLM)101137239
040 $aDNLM/DLC$cDLC$dDLC
042 $apcc
050 00 $aRS431.P75$bD485 2002
060 10 $aW1$bPH151N v.14 2002
060 10 $aQV 744$bD489 2002
082 00 $a615/.19$221
245 00 $aDevelopment and manufacture of protein pharmaceuticals /$cedited by Steve L. Nail and Michael J. Akers.
260 $aNew York :$bKluwer Academic/Plenum Publishers,$cc2002.
300 $axx, 462 p. :$bill. ;$c24 cm.
440 0 $aPharmaceutical biotechnology ;$vv. 14
504 $aIncludes bibliographical references and index.
650 0 $aProtein drugs.
650 12 $aChemistry, Pharmaceutical$xmethods.
650 12 $aTechnology, Pharmaceutical$xmethods.
650 22 $aPeptides$xpharmacology.
650 22 $aProteins$xpharmacology.
700 1 $aNail, Steven L.
700 1 $aAkers, Michael J.
856 42 $3Publisher description$uhttp://www.loc.gov/catdir/enhancements/fy0819/2002016154-d.html
856 41 $3Table of contents only$uhttp://www.loc.gov/catdir/enhancements/fy0819/2002016154-t.html